Search Results - her2%2fneu+receptor

2 Results Sort By:
Anticancer Agents for Triple-Negative Breast Cancers
Selectively Kills EGFR+, HER2+, and HER+3 Tumors via New Mechanism, Enabling These Tumors to Overcome Resistance to Current TherapyThis first-in-class compound selectively kills cancer cells without harming normal tissues. The Epidermal Growth Factor Receptor (EGFR) family members -- EGFR, Human Epidermal Growth Factor Receptor-2 (HER2) and Human Epidermal...
Published: 11/19/2021   |   Inventor(s): Brian Law, Ronald Castellano
Keywords(s): Akt, breast cancer, Compound, EGFR, Her2, HER2/neu receptor, Therapeutic
Category(s): Technology Classifications > Human Health Care > Therapeutics
Gene Transfer Vector for Treating HER2/neu-positive Breast Cancer Metastasis in Bone Marrow
More Effective Treatment Has Fewer Side Effects, Wider ApplicationsThis gene transfer vector helps locate and destroy malignant breast cancer cells that have spread to the bone marrow by delivering tumor-suppressing genes or cytotoxic drugs to wherever they are needed in the patient’s body. In about 25 percent of breast cancers, a protein called...
Published: 6/27/2021   |   Inventor(s): Mavis Agbandje-McKenna, Kirsten Weigel-Van Aken
Keywords(s): breast cancer metastases in the human bone ma, HER2/neu receptor, HER2/neu-targeting viral vector, human parvovirus B19
Category(s): Technology Classifications > Human Health Care > Therapeutics